Dorman (DORM) CFO awarded 2,587 restricted stock units vesting from 2027

Rhea-AI Filing Summary

Dorman Products, Inc. reported that its Senior Vice President, Chief Financial Officer and Treasurer, Charles W. Rayfield, acquired an equity award tied to the company’s common stock. He received 2,587 restricted stock units, valued using a reference price of $115.93 per share, bringing his reported direct holdings from this grant to 2,587 units.

The footnote explains that these are restricted stock units representing a contingent right to receive Dorman common shares. They will vest in three equal annual installments beginning on March 2, 2027, the first anniversary of the grant date, meaning the award delivers shares over time rather than as an immediate cash transaction.

Insights

Equity Compensation Analyst

Routine equity grant to CFO with three-year vesting, neutral impact.

The transaction shows Dorman’s CFO, Charles W. Rayfield, receiving 2,587 restricted stock units, classified as a grant or award acquisition at a reference price of $115.93 per share. This is a non-derivative equity award rather than an open-market purchase or sale.

The award vests in three equal annual installments starting on March 2, 2027, spreading the potential share delivery over three years. This structure is typical for senior executive compensation and aims to align the officer’s interests with longer-term company performance, without indicating any immediate change in the company’s fundamentals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rayfield Charles W

(Last) (First) (Middle)

C/O DORMAN PRODUCTS, INC

3400 EAST WALNUT STREET

(Street)

COLMAR PA 18915

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dorman Products, Inc. [ DORM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CFO , Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		A		2,587(1)	A	$115.93	2,587	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in three equal annual installments beginning on March 2, 2027, which is the first anniversary of the date of grant.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.

	/s/ Frank J. Mahr, by Power of Attorney	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Dorman Products (DORM) report for Charles W. Rayfield?

Dorman Products reported that CFO Charles W. Rayfield received a grant of 2,587 restricted stock units tied to the company’s common stock. The award is classified as a grant or award acquisition, not an open-market purchase or sale of shares.

At what price was the new equity award to Dorman’s CFO measured?

The 2,587 restricted stock units granted to Dorman’s CFO used a reference price of $115.93 per share. This price reflects how the award’s size is measured in the filing, rather than a cash transaction executed in the open market.

How many Dorman equity units does the CFO hold after this Form 4 transaction?

Following this reported transaction, the Form 4 lists Charles W. Rayfield as holding 2,587 units related to Dorman common stock. These units stem from the newly granted restricted stock award and reflect his direct ownership reported in this filing.

When do the restricted stock units granted to Dorman’s CFO vest?

The restricted stock units vest in three equal annual installments starting March 2, 2027. That date is the first anniversary of the grant, meaning the award delivers Dorman common shares gradually over three years as vesting conditions are met.

Are the Dorman (DORM) shares in this Form 4 immediately issued to the CFO?

No, the footnote explains these are restricted stock units representing a contingent right to receive Dorman common shares. Actual shares are delivered over time as the units vest in three equal installments beginning March 2, 2027.

Is the Dorman Products Form 4 transaction a buy or sell in the open market?

The transaction is reported as a grant, award, or other acquisition, not an open-market buy or sell. It reflects equity compensation in the form of restricted stock units, rather than the CFO trading existing Dorman shares on the market.